Golden has been acquired by ComplyAdvantage.Read about it here ⟶

List of American Gene Technologies patents

Patents where

Current Assignee

Name

American Gene Technologies

Name	Description	Patent Applicant	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent 11617760 Safe lentiviral vectors for targeted delivery of multiple therapeutic molecules	Patent 11617760 was granted and assigned to American Gene Technologies on April, 2023 by the United States Patent and Trademark Office.	American Gene Technologies	American Gene Technologies	United States Patent and Trademark Office	11617760	April 4, 2023
‌ US Patent 10233464 HIV pre-immunization and immunotherapy	Patent 10233464 was granted and assigned to American Gene Technologies on March, 2019 by the United States Patent and Trademark Office.	American Gene Technologies	American Gene Technologies	United States Patent and Trademark Office	10233464	March 19, 2019
‌ US Patent 10023880 Methods and compositions for the activation of gamma-delta T-cells	Patent 10023880 was granted and assigned to American Gene Technologies on July, 2018 by the United States Patent and Trademark Office.	American Gene Technologies	American Gene Technologies	United States Patent and Trademark Office	10023880	July 17, 2018
‌ US Patent 10137144 Methods and compositions for the activation of gamma-delta T-cells	Patent 10137144 was granted and assigned to American Gene Technologies on November, 2018 by the United States Patent and Trademark Office.	American Gene Technologies	American Gene Technologies	United States Patent and Trademark Office	10137144	November 27, 2018
‌ US Patent 11583562 Viral vectors for treating Parkinson's disease		American Gene Technologies	American Gene Technologies	United States Patent and Trademark Office	11583562	February 21, 2023
‌ US Patent 10036038 HIV pre-immunization and immunotherapy	Patent 10036038 was granted and assigned to American Gene Technologies on July, 2018 by the United States Patent and Trademark Office.	American Gene Technologies	American Gene Technologies	United States Patent and Trademark Office	10036038	July 31, 2018
‌ US Patent 10036040 Methods and compositions for the activation of gamma-delta T-cells	Patent 10036040 was granted and assigned to American Gene Technologies on July, 2018 by the United States Patent and Trademark Office.	American Gene Technologies	American Gene Technologies	United States Patent and Trademark Office	10036040	July 31, 2018
‌ US Patent 10420789 Methods and compositions for the activation of gamma-delta T-cells	Patent 10420789 was granted and assigned to American Gene Technologies on September, 2019 by the United States Patent and Trademark Office.	American Gene Technologies	American Gene Technologies	United States Patent and Trademark Office	10420789	September 24, 2019
‌ US Patent 10472649 Methods and compositions for the activation of gamma-delta T-cells	Patent 10472649 was granted and assigned to American Gene Technologies on November, 2019 by the United States Patent and Trademark Office.	American Gene Technologies	American Gene Technologies	United States Patent and Trademark Office	10472649	November 12, 2019
‌ US Patent 11352646 Vector system for expressing regulatory RNA	Patent 11352646 was granted and assigned to American Gene Technologies on June, 2022 by the United States Patent and Trademark Office.	American Gene Technologies	American Gene Technologies	United States Patent and Trademark Office	11352646	June 7, 2022
‌ US Patent 10888613 Method of producing cells resistant to HIV infection	Patent 10888613 was granted and assigned to American Gene Technologies on January, 2021 by the United States Patent and Trademark Office.	American Gene Technologies	American Gene Technologies	United States Patent and Trademark Office	10888613	January 12, 2021
‌ US Patent 11519006 Methods and compositions for the activation of gamma-delta T-cells		American Gene Technologies	American Gene Technologies	United States Patent and Trademark Office	11519006	December 6, 2022
‌ US Patent 9914938 Methods and compositions for the activation of gamma-delta T-cells	Patent 9914938 was granted and assigned to American Gene Technologies on March, 2018 by the United States Patent and Trademark Office.	American Gene Technologies	American Gene Technologies	United States Patent and Trademark Office	9914938	March 13, 2018
‌ US Patent 10494647 HIV pre-immunization and immunotherapy	Patent 10494647 was granted and assigned to American Gene Technologies on December, 2019 by the United States Patent and Trademark Office.	American Gene Technologies	American Gene Technologies	United States Patent and Trademark Office	10494647	December 3, 2019
‌ US Patent 11534450 Methods and compositions for the activation of gamma-delta T-cells	Patent 11534450 was granted and assigned to American Gene Technologies on December, 2022 by the United States Patent and Trademark Office.	American Gene Technologies	American Gene Technologies	United States Patent and Trademark Office	11534450	December 27, 2022
‌ US Patent 10975374 Combination vectors and methods for treating cancer	Patent 10975374 was granted and assigned to American Gene Technologies on April, 2021 by the United States Patent and Trademark Office.	American Gene Technologies	American Gene Technologies	United States Patent and Trademark Office	10975374	April 13, 2021
‌ US Patent 10428350 Methods and compositions for the activation of gamma-delta T-cells	Patent 10428350 was granted and assigned to American Gene Technologies on October, 2019 by the United States Patent and Trademark Office.	American Gene Technologies	American Gene Technologies	United States Patent and Trademark Office	10428350	October 1, 2019
‌ US Patent 11242527 Combination vectors and methods for treating cancer	Patent 11242527 was granted and assigned to American Gene Technologies on February, 2022 by the United States Patent and Trademark Office.	American Gene Technologies	American Gene Technologies	United States Patent and Trademark Office	11242527	February 8, 2022
‌ US Patent 10767183 Combination vectors and methods for treating cancer		American Gene Technologies	American Gene Technologies	United States Patent and Trademark Office	10767183	September 8, 2020
‌ US Patent 11007209 Safe lentiviral vectors for targeted delivery of multiple therapeutic molecules	Patent 11007209 was granted and assigned to American Gene Technologies on May, 2021 by the United States Patent and Trademark Office.	American Gene Technologies	American Gene Technologies	United States Patent and Trademark Office	11007209	May 18, 2021
‌ US Patent 10772905 Methods and compositions for the activation of gamma-delta T-cells		American Gene Technologies	American Gene Technologies	United States Patent and Trademark Office	10772905	September 15, 2020
‌ US Patent 10548914 Safe lentiviral vectors for targeted delivery of multiple therapeutic molecules	Patent 10548914 was granted and assigned to American Gene Technologies on February, 2020 by the United States Patent and Trademark Office.		American Gene Technologies	United States Patent and Trademark Office	10548914	February 4, 2020

22 results

0 selected

22 results

0 selected